This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2005-2007.
Company Filing History:
Years Active: 2005-2007
Title: Innovations by Timothy J McDonnell
Introduction
Timothy J McDonnell is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 2 patents, McDonnell's work focuses on the treatment of Bcl-2-associated diseases, particularly follicular lymphoma.
Latest Patents
McDonnell's latest patents include "Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides." This invention provides novel compositions and methods for treating Bcl-2-associated diseases like cancer. The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, inhibiting the proliferation of follicular lymphoma cancer cells. Another significant patent is "Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery." This invention relates to viral vectors and their use as expression vectors for transforming human cells, particularly in cancer therapy.
Career Highlights
Timothy J McDonnell is affiliated with the University of Texas System, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies for cancer patients.
Collaborations
McDonnell has collaborated with notable colleagues, including Mar Tormo and Ana Maria Tari, contributing to the advancement of cancer research and therapy.
Conclusion
Timothy J McDonnell's innovative work and patents reflect his commitment to improving cancer treatment options. His contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in medicine.